Company · CIK 1410064
ARYx Therapeutics, Inc.
| CIK | 1410064 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2007-12-21 |
Offerings
5 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-169891 | 2010-10-12 | 2010-10-21 | 2 | |
| 333-166985 | 2010-05-20 | 2010-06-04 | 4 | |
| 333-163238 | 2009-11-20 | 2009-12-09 | 3 | |
| 333-156286 | 2008-12-18 | 2009-01-08 | 2 | |
| 333-145813 | 2007-08-30 | 2007-11-08 | 7 |
Filings
18| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2010-10-21 | EFFECTDeclared effective | 333-169891 | 9999999995-10-003012 |
| 2010-10-12 | S-3Shelf registered | 333-169891 | 0001104659-10-052099 |
| 2010-06-04 | 424B5Shelf takedown | 333-166985 | 0001047469-10-005772 |
| 2010-06-02 | EFFECTDeclared effective | 333-166985 | 9999999995-10-001690 |
| 2010-05-20 | 424B5Shelf takedown | 333-166985 | 0001047469-10-005476 |
| 2010-05-20 | S-3Shelf registered | 333-166985 | 0001047469-10-005474 |
| 2009-12-09 | EFFECTDeclared effective | 333-163238 | 9999999995-09-003423 |
| 2009-12-02 | S-1/AAmendment | 333-163238 | 0001104659-09-068263 |
| 2009-11-20 | S-1Registration filed | 333-163238 | 0001104659-09-066058 |
| 2009-01-08 | EFFECTDeclared effective | 333-156286 | 9999999995-09-000054 |
| 2008-12-18 | S-3Shelf registered | 333-156286 | 0001047469-08-013264 |
| 2007-11-08 | 424B1Final prospectus | 333-145813 | 0001047469-07-008647 |
| 2007-11-07 | EFFECTDeclared effective | 333-145813 | 9999999995-07-004408 |
| 2007-11-07 | S-1/AAmendment | 333-145813 | 0001047469-07-008550 |
| 2007-11-05 | S-1/AAmendment | 333-145813 | 0001047469-07-008368 |
| 2007-10-23 | S-1/AAmendment | 333-145813 | 0001047469-07-007847 |
| 2007-10-03 | S-1/AAmendment | 333-145813 | 0001047469-07-007395 |
| 2007-08-30 | S-1Registration filed | 333-145813 | 0001047469-07-006769 |